NASDAQ$VCEL
Vericel Corporation · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
Reported a strong first quarter with revenue growth and increased profitability.
Vericel Corporation reported a 30% increase in total net revenue to $34.6 million for the first quarter of 2021, driven by strong performance in both sports medicine and burn care franchises. The company raised its full-year 2021 revenue guidance to $165 - $168 million and reported a net loss of $3.3 million, or $0.07 per share.
- Total net revenue increased by 30% to $34.6 million compared to the first quarter of 2020.
- MACI net revenue was $23.8 million, and Epicel net revenue was $9.8 million.
- Net loss was $3.3 million, or $0.07 per share, compared to $4.7 million, or $0.10 per share, in the first quarter of 2020.
- The company had $110 million in cash and investments as of March 31, 2021.
Headline financials
Revenue & EPS history
Vericel · Revenue · Quarterly
$34.6M
Revenue by segment
Vericel · $34.5M total across 3 segments · Q1 2021
- MACI$23.8M+17.2%69.0%
- Epicel$9.8M+53.1%28.4%
- NexoBrid$900K—2.6%
Forward guidance
Vericel expects total net revenue to be in the range of $165-$168 million and adjusted EBITDA margin to be in the range of 21.5% to 23.5% for the full year 2021. Gross margin guidance of 70% to 71% and estimated operating expenses of approximately $115 million maintained.
Tailwinds
- Total net revenue expected to be in the range of $165-$168 million.
- Adjusted EBITDA margin expected to be in the range of 21.5% to 23.5%.
- Gross margin guidance of 70% to 71% maintained.
- Estimated operating expenses of approximately $115 million maintained.
Headwinds
- Uncertainties associated with future revenue growth.
- Potential fluctuations in sales and volumes.
- Timing and conduct of clinical trial and product development activities.
- Competitive developments and changes in third-party coverage and reimbursement.
- Impacts of the COVID-19 pandemic on the business.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2021
+1.4%
Avg return
Earnings day
+2.8%
Avg return
5 days after
+2.2%
Avg return
30 days after
47%
30 / 64 earnings
Positive
+48.1%
Q3 2018
Best reaction
-30.0%
Q2 2013
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -4.6% | -10.4% | -1.4% | |
| Q4 2025 | +1.7% | -7.3% | -20.9% | |
| Q3 2025 | +4.6% | +10.3% | -2.6% | |
| Q1 2025 | +3.2% | +7.8% | +7.0% | |
| Q4 2024 | -6.1% | -3.2% | -15.8% | |
| Q3 2024 | +12.4% | +16.3% | +17.3% | |
| Q2 2024 | -5.7% | -7.5% | +2.2% | |
| Q1 2024 | -1.8% | -2.0% | -10.4% | |
| Q4 2023 | -6.5% | -7.0% | +8.8% | |
| Q3 2023 | -11.2% | -7.0% | -7.3% | |
| Q2 2023 | -8.9% | -9.2% | -3.5% | |
| Q1 2023 | +0.5% | +2.8% | +6.5% | |
| Q4 2022 | +6.9% | +6.6% | +1.6% | |
| Q3 2022 | -2.8% | +0.2% | -0.3% | |
| Q2 2022 | -4.3% | -6.2% | -28.7% | |
| Q1 2022 | -9.1% | -18.9% | -13.1% | |
| Q4 2021 | +21.9% | +26.4% | +11.2% | |
| Q3 2021 | -2.7% | -3.0% | -10.6% | |
| Q2 2021 | -2.1% | -4.5% | +9.0% | |
| Q1 2021 | -10.2% | -15.9% | -5.8% | |
| Q4 2020 | +0.4% | +1.7% | +9.0% | |
| Q3 2020 | +6.0% | +17.7% | +18.5% | |
| Q2 2020 | -9.8% | -5.0% | -5.5% | |
| Q1 2020 | +5.6% | +8.3% | +3.9% | |
| Q4 2019 | -20.4% | -18.3% | -46.9% | |
| Q3 2019 | +15.3% | +15.7% | +12.9% | |
| Q2 2019 | +2.4% | +1.9% | -8.3% | |
| Q1 2019 | -2.5% | -3.6% | -16.8% | |
| Q4 2018 | -7.4% | -3.5% | -13.6% | |
| Q3 2018 | +48.1% | +39.6% | +53.3% | |
| Q2 2018 | +25.6% | +27.1% | +36.5% | |
| Q1 2018 | +6.0% | +5.6% | +0.4% | |
| Q4 2017 | +40.1% | +38.3% | +33.5% | |
| Q3 2017 | -7.0% | -5.8% | +14.0% | |
| Q2 2017 | +11.7% | +21.7% | +48.3% | |
| Q1 2017 | +0.0% | +3.9% | +5.9% | |
| Q4 2016 | -1.7% | +0.0% | -6.9% | |
| Q3 2016 | -2.3% | +4.7% | +9.3% | |
| Q2 2016 | -5.5% | -7.7% | -5.5% | |
| Q1 2016 | +11.5% | — | — | |
| Q4 2015 | +4.8% | — | — | |
| Q3 2015 | -9.7% | — | — | |
| Q2 2015 | +4.3% | — | — | |
| Q1 2015 | -2.5% | — | — | |
| Q4 2014 | +2.9% | — | — | |
| Q3 2014 | +3.6% | — | — | |
| Q2 2014 | -0.3% | — | — | |
| Q1 2014 | +0.5% | — | — | |
| Q4 2013 | -12.7% | — | — | |
| Q3 2013 | -2.2% | — | — | |
| Q2 2013 | -30.0% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q4 2012 | -6.3% | — | — | |
| Q3 2012 | -4.0% | — | — | |
| Q2 2012 | -6.5% | — | — | |
| Q1 2012 | -0.8% | — | — | |
| Q4 2011 | +1.0% | — | — | |
| Q3 2011 | +3.1% | — | — | |
| Q2 2011 | +8.3% | — | — | |
| Q1 2011 | +4.7% | — | — | |
| Q4 2009 | +4.7% | — | — | |
| Q3 2010 | +35.3% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q1 2010 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro